Italfarmaco
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Italfarmaco
RECRUITINGPhase 2NCT06769633
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
This is a Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in younger DMD Patients. * Planned...
Sponsor: ItalfarmacoEnrolling: 189 locations
Duchenne Muscular Dystrophy
RECRUITINGPhase 3NCT05933057
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
This is a randomised, double-blind, placebo-controlled, multicentre study to evaluate the efficacy, safety, and tolerability of givinostat in non-ambulant male paediatric (aged 9...
Sponsor: ItalfarmacoEnrolling: 13820 locations
Duchenne Muscular Dystrophy
RECRUITINGPhase 2 / Phase 3NCT03373968
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one...
Sponsor: ItalfarmacoEnrolling: 20620 locations
Duchenne Muscular Dystrophy